US
US Testosterone Replacement Therapy Market Industry Trends and Forecast to 2034: Segmented by (Form, Channel, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
US · 2024–2034 · estimates
Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
US (this report) at $749.7 Mn.
Canada at 4% a year.Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$170.3 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $732.9 Mn | — | — |
| 2025 (base) | $749.7 Mn | +$16.9 Mn | — |
| 2026 (forecast) | $767.0 Mn | +$17.2 Mn | +2.3% |
| 2027 (forecast) | $784.6 Mn | +$17.6 Mn | +4.7% |
| 2028 (forecast) | $802.7 Mn | +$18.0 Mn | +7.1% |
| 2029 (forecast) | $821.1 Mn | +$18.5 Mn | +9.5% |
| 2030 (forecast) | $840.0 Mn | +$18.9 Mn | +12% |
| 2031 (forecast) | $859.3 Mn | +$19.3 Mn | +14.6% |
| 2032 (forecast) | $879.1 Mn | +$19.8 Mn | +17.3% |
| 2033 (forecast) | $899.3 Mn | +$20.2 Mn | +20% |
| 2034 (forecast) | $920.0 Mn | +$20.7 Mn | +22.7% |
Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
US (this report)
$749.7 Mn
Canada
$186.1 Mn
China
$169.1 Mn
Japan
$153.4 Mn
Germany
$85.0 Mn
France
$66.7 Mn
UK
$61.2 Mn
Brazil
$53.3 Mn
Italy
$49.5 Mn
India
$43.8 Mn
Ecuador
$38.8 Mn
Spain
$36.1 Mn
Saudi Arabia
$36.8 Mn
Mexico
$35.5 Mn
Australia
$29.4 Mn
Russia
$20.3 Mn
New Zealand
$19.6 Mn
South Africa
$16.3 Mn
UAE
$11.2 Mn
Egypt
$6.3 Mn
Philippines
$5.4 Mn
Hong Kong
$3.7 Mn
Malaysia
$3.3 Mn
Singapore
$2.6 Mn
Thailand
$2.4 Mn
Kenya
$1.6 Mn
Testosterone replacement therapy treats low testosterone in men with gels, injections, patches and pellets.
Key segments of the testosterone Replacement Therapy market include form (Injections, Gels and Patches) and channel (Clinics, Telehealth and Pharmacies).
An ageing male population, more men seeking care, less invasive procedures and telehealth for sensitive conditions are driving the testosterone Replacement Therapy market.
Office-based procedures, direct-to-consumer telehealth and wider insurance coverage give the testosterone Replacement Therapy market room to grow.
Stigma, out-of-pocket costs and limited reimbursement for some procedures hold back the testosterone Replacement Therapy market.
The testosterone Replacement Therapy market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for testosterone Replacement Therapy. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in US.
What doctors and scientists are doing in Testosterone Replacement Therapy right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
From our blog
US · 3 shared keywords
US · 1 shared keyword
US · 1 shared keyword
US · 1 shared keyword
US · 1 shared keyword
US · 1 shared keyword
Medical Devices · US
Healthcare Services · US
Healthcare Services · US
Medical Devices · US
Healthcare Services · US
Medical Devices · US